U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. From Our Perspective
  1. News & Events for Human Drugs

From Our Perspective

Insights from CDER leadership and experts on public health actions

FDA actions to continue to ensure the safety of the nation’s drug supply

By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research

One of FDA’s top priorities is ensuring the safety, quality, and effectiveness of the drug products available to the American public. Manufacturers of drugs intended for the U.S. market, including over-the-counter monograph drug products, are obligated to ensure that their products comply with Current Good Manufacturing Practice (CGMP) requirements and appropriate quality specifications. 

More with Patrizia Cavazzoni, M.D.

Previous From Our Perspectives

Back to Top